DEVELOPMENT AND VALIDATION OF THE METHOD FOR DETERMINING THE QUANTITATIVE CONTENT 5-[2-(3-TRET-BUTYLAMINO-2-HYDROXYPROPOXY)PHENOXYMETHYL]-3-METHYL-1,2,4-OXADIAZOLEHYDROCHLORIDE IN OCULAR DRUG FILMS FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA

DEVELOPMENT AND VALIDATION OF THE METHOD FOR DETERMINING THE QUANTITATIVE CONTENT 5-[2-(3-TRET-BUTYLAMINO-2-HYDROXYPROPOXY)PHENOXYMETHYL]-3-METHYL-1,2,4-OXADIAZOLEHYDROCHLORIDE IN OCULAR DRUG FILMS FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA

Developed method for the quantitative determination of 5-[2-(3-tret-butylamino-2-hydroxypropoxy) phenoxymethyl]-3-methyl-1,2,4-oxadiazole hydrochloride in polymer drug films by UV-spectrometry. The method was validated by indicators such as accuracy, specificity, analytical area, the linearity and c...

Full description

Bibliographic Details
Main Authors: M. V. Bolshakova, M. A. Burakova, B. O. Alekseev
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
валидация
количественное определение
лекарственные пленки
уф-спектрометрия
Online Access:https://www.pharmjournal.ru/jour/article/view/90

Internet

https://www.pharmjournal.ru/jour/article/view/90

Similar Items